Evidence map›Paper›PMID 23884469›Full record

ArticleScience translational medicine2013

CaMKII is essential for the proasthmatic effects of oxidation.

Philip N Sanders, Olha M Koval, Omar A Jaffer, Anand M Prasad, Thomas R Businga, Jason A Scott, Patrick J Hayden, Elizabeth D Luczak, David D Dickey, Chantal Allamargot and 19 more

Abstract read
In one paragraph

Article in Science translational medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 63 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. CaMKII oxidation regulates cockroach allergen-induced mitophagy in asthma.The Journal of allergy and clinical immunology · 2021
    Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Inhibitor 1 of Protein Phosphatase 1 Regulates CaOxidative medicine and cellular longevity · 2019
    Article
  17. Review
  18. Novel eosinophilic gene expression networks associated with IgE in two distinct asthma populations.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2018
    Article
  19. Review
  20. The vagal ganglia transcriptome identifies candidate therapeutics for airway hyperreactivity.American journal of physiology. Lung cellular and molecular physiology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 5 institutions in 1 country.

Philip N SandersDepartment of Internal Medicine, Carver College of Medicine, University of Iowa, Iowa City, IA 52242, USA.
Olha M Koval
Omar A Jaffer
Anand M Prasad
Thomas R Businga
Jason A Scott
Patrick J Hayden
Elizabeth D Luczak
David D Dickey
Chantal Allamargot
Alicia K Olivier
David K Meyerholz
Alfred J Robison
Danny G Winder
Timothy S Blackwell
Ryszard Dworski
David Sammut
Brett A Wagner
Garry R Buettner
Robert M Pope
Francis J Miller
Megan E Dibbern
Hans Michael Haitchi
Peter J Mohler
Peter H Howarth
Joseph Zabner
Joel N Kline
Isabella M Grumbach
Mark E Anderson
University of Iowa · USAshland (United States) · USMichigan State University · USThe Ohio State University Wexner Medical Center · USVanderbilt University · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI DRAKE, WONDER P. · 1985 to 2008
$38.3M
Quantitative Redox BiologyR01GM073929 · NIGMS · UNIVERSITY OF IOWA · PI BUETTNER, GARRY R · 2008 to 2011
$1.5M
Oxidant Stress and Allergic AsthmaK23HL080030 · NHLBI · VANDERBILT UNIVERSITY · PI DWORSKI, RYSZARD T · 2006 to 2009
$609k
Medical Research Council G0800649Medical Research Council G0802804Medical Research Council G0900453NCI NIH HHS P30 CA086862NCRR NIH HHS M01 RR000095NCRR NIH HHS M01 RR-00095NHLBI NIH HHS K23 HL080030NHLBI NIH HHS K23 HL080030-02NIEHS NIH HHS P30 ES005605NIGMS NIH HHS R01 GM073929
6 · The paper itself

Abstract

Increased reactive oxygen species (ROS) contribute to asthma, but little is known about the molecular mechanisms connecting increased ROS with characteristic features of asthma. We show that enhanced oxidative activation of the Ca(2+)/calmodulin-dependent protein kinase (ox-CaMKII) in bronchial epithelium positively correlates with asthma severity and that epithelial ox-CaMKII increases in response to inhaled allergens in patients. We used mouse models of allergic airway disease induced by ovalbumin (OVA) or Aspergillus fumigatus (Asp) and found that bronchial epithelial ox-CaMKII was required to increase a ROS- and picrotoxin-sensitive Cl(-) current (ICl) and MUC5AC expression, upstream events in asthma progression. Allergen challenge increased epithelial ROS by activating NADPH oxidases. Mice lacking functional NADPH oxidases due to knockout of p47 and mice with epithelial-targeted transgenic expression of a CaMKII inhibitory peptide or wild-type mice treated with inhaled KN-93, an experimental small-molecule CaMKII antagonist, were protected against increases in ICl, MUC5AC expression, and airway hyperreactivity to inhaled methacholine. Our findings support the view that CaMKII is a ROS-responsive, pluripotent proasthmatic signal and provide proof-of-concept evidence that CaMKII is a therapeutic target in asthma.

Indexed as

Administration, IntranasalAnimalsAsthmaBenzenesulfonamidesBenzylaminesBlotting, WesternBronchiCalcium-Calmodulin-Dependent Protein Kinase Type 2FemaleHumansIn Vitro TechniquesMaleMiceNADPH OxidasesOvalbuminOxidation-ReductionBenzenesulfonamidesBenzylaminesCalcium-Calmodulin-Dependent Protein Kinase Type 2KN 93NADPH OxidasesOvalbuminProtein Kinase InhibitorsReactive Oxygen SpeciesSulfonamides

Identifiers

PMID23884469
PMCPMC4331168
OpenAlexW2113892738

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.